Imugene (ASX: IMU)
Latest
-
Changing the lives of cancer patients - Dr Leslie Chong of Imugene | ASX CEO Connect Series
Dr Chong is the CEO and Managing Director of Imugene, an ASX-listed biotechnology company working to change the paradigm of cancer treatment - trading under the ASX ticker IMU. Dr Chong has over 20 years experience in leading clinical and department development in oncology including at major pharmaceutical companies Genentech, GSK and Roche.31 March
Sponsored by Australian Securities Exchange (ASX)